Water-soluble lipophilic MR contrast agents for cell membrane labeling
- PMID: 26215869
- PMCID: PMC4546878
- DOI: 10.1007/s00775-015-1280-4
Water-soluble lipophilic MR contrast agents for cell membrane labeling
Abstract
Long-term cell tracking using MR imaging necessitates the development of contrast agents that both label and are retained by cells. One promising strategy for long-term cell labeling is the development of lipophilic Gd(III)-based contrast agents that anchor into the cell membrane. We have previously reported the efficacy of monomeric and multimeric lipophilic agents and showed that the monomeric agents have improved labeling and contrast enhancement of cell populations. Here, we report on the synthesis, characterization, and in vitro testing of a series of monomeric lipophilic contrast agents with varied alkyl chain compositions. We show that these agents disperse in water, localize to the cell membrane, and label HeLa and MCF7 cells effectively. Additionally, these agents have up to tenfold improved retention in cells compared to clinically available ProHance(®).
Figures




Similar articles
-
Cell labeling via membrane-anchored lipophilic MR contrast agents.Bioconjug Chem. 2014 May 21;25(5):945-54. doi: 10.1021/bc500083t. Epub 2014 May 9. Bioconjug Chem. 2014. PMID: 24787689 Free PMC article.
-
Nanodiscs as a Modular Platform for Multimodal MR-Optical Imaging.Bioconjug Chem. 2015 May 20;26(5):899-905. doi: 10.1021/acs.bioconjchem.5b00107. Epub 2015 Apr 9. Bioconjug Chem. 2015. PMID: 25830565 Free PMC article.
-
Improving T₁ and T₂ magnetic resonance imaging contrast agents through the conjugation of an esteramide dendrimer to high-water-coordination Gd(III) hydroxypyridinone complexes.Contrast Media Mol Imaging. 2012 Jan-Feb;7(1):95-9. doi: 10.1002/cmmi.483. Contrast Media Mol Imaging. 2012. PMID: 22344885 Free PMC article.
-
Promising strategies for Gd-based responsive magnetic resonance imaging contrast agents.Curr Opin Chem Biol. 2013 Apr;17(2):158-66. doi: 10.1016/j.cbpa.2012.10.031. Epub 2012 Nov 8. Curr Opin Chem Biol. 2013. PMID: 23141598 Review.
-
Gadolinium(III)-based blood-pool contrast agents for magnetic resonance imaging: status and clinical potential.Expert Opin Drug Deliv. 2007 Mar;4(2):149-64. doi: 10.1517/17425247.4.2.149. Expert Opin Drug Deliv. 2007. PMID: 17335412 Review.
Cited by
-
Modulating the Properties of Fe(III) Macrocyclic MRI Contrast Agents by Appending Sulfonate or Hydroxyl Groups.Molecules. 2020 May 13;25(10):2291. doi: 10.3390/molecules25102291. Molecules. 2020. PMID: 32414058 Free PMC article.
-
An Efficient T 1 Contrast Agent for Labeling and Tracking Human Embryonic Stem Cells on MRI.Contrast Media Mol Imaging. 2019 Jun 16;2019:3475786. doi: 10.1155/2019/3475786. eCollection 2019. Contrast Media Mol Imaging. 2019. PMID: 31316306 Free PMC article.
-
Dinuclear Fe(III) Hydroxypropyl-Appended Macrocyclic Complexes as MRI Probes.Inorg Chem. 2021 Jun 21;60(12):8651-8664. doi: 10.1021/acs.inorgchem.1c00634. Epub 2021 Jun 10. Inorg Chem. 2021. PMID: 34110140 Free PMC article.
References
-
- Valone FH, Small E, MacKenzie M, Burch P, Lacy M, Peshwa MV, Laus R. Cancer J. 2001;7:S53–S61. - PubMed
-
- Fernandez-Aviles F, San Roman JA, Garcia-Frade J, Fernandez ME, Penarrubia MJ, de la Fuente L, Gomez-Bueno M, Cantalapiedra A, Fernandez J, Gutierrez O, Sanchez PL, Hernandez C, Sanz R, Garcia-Sancho J, Sanchez A. Circulation research. 2004;95:742–748. - PubMed
-
- Semsarian C. Internal medicine journal. 2002;32:259–265. - PubMed
-
- Petit-Zeman S. Nature biotechnology. 2001;19:201–206. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources